Zobrazeno 1 - 7
of 7
pro vyhledávání: '"L Ulacia Epelde"'
Autor:
L Ulacia Epelde, I Ortega Belio, N Larrea Goñi, A Egüés Lugea, R de la Riva Bohigas, P Aldave Cobos, I Irigoyen Rodriguez, D Fresán Restituto, A Lamas Pillo, A Rodríguez Esquíroz, D Tejada Marín
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ec57c7d2d800ce9e4c1845b60dfc0f0
https://doi.org/10.1136/ejhpharm-2022-eahp.346
https://doi.org/10.1136/ejhpharm-2022-eahp.346
Autor:
M Sarobe Carricas, J.J. Elizondo Armendáriz, G Pinilla Lebrero, A Rodríguez Esquíroz, L Ulacia Epelde, I Ortega Belio, D Fresan Restituto, D Tejada Marín, M Calvo Arbeloa, JA Illodo Becerra
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines recommend the optimisation of the nutritional status of patients with SARSCoV- 2 infection through dietary advice and/or oral nutritional suppleme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::285f71b0f54b9e0c7f5c90bfc2047417
https://doi.org/10.1136/ejhpharm-2021-eahpconf.192
https://doi.org/10.1136/ejhpharm-2021-eahpconf.192
Autor:
G Pinilla Lebrero, E Lacalle Fabo, P Aldave Cobos, L Ulacia Epelde, JA Illodo Becerra, J.J. Elizondo Armendáriz, D Fresan Restituto, M Sarobe Carricas, J Polo García, M Calvo Arbeloa
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Severe uncontrolled asthma is characterised by poor control despite treatment with inhaled glucocorticoids (IGC) and beta2 adrenergic agonists (LABA) at high doses, and/or oral glucocorticoids (OGC). This type of asthma comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7f3ac6438d21ea68b69b9fd181c409f
https://doi.org/10.1136/ejhpharm-2020-eahpconf.243
https://doi.org/10.1136/ejhpharm-2020-eahpconf.243
Autor:
G Pinilla Lebrero, J.J. Elizondo Armendáriz, A Egües Lugea, J Polo García, A Rodríguez Esquíroz, P Aldave Cobos, L Ulacia Epelde
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Enteral nutrition (EN) through a feeding tube is a frequent method of nutrition support in the hospital environment. This method of delivering nutrition is also commonly used for administering medications when patients canno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd019d1e770ae30ad71de2e7e85d826d
https://doi.org/10.1136/ejhpharm-2020-eahpconf.402
https://doi.org/10.1136/ejhpharm-2020-eahpconf.402
Autor:
A Rodríguez Esquíroz, M Sarobe Carricas, G Pinilla Lebrero, J.J. Elizondo Armendáriz, P Aldave Cobos, L Ulacia Epelde, J Polo García, JA Illodo Becerra, A Arrondo Velasco, D Tejada Marín, M Calvo Arbeloa
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Biological treatments have improved the therapeutic options for inflammatory bowel disease (IBD) and have shown high clinical efficacy. Nevertheless, some patients do not respond to initial treatment or present loss of respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0c7e6db21c41cdb36850d811ab73493
https://doi.org/10.1136/ejhpharm-2020-eahpconf.228
https://doi.org/10.1136/ejhpharm-2020-eahpconf.228
Autor:
J.J. Elizondo Armendáriz, M Calvo Arbeloa, D Tejada Marín, G Pinilla Lebrero, J Polo García, A Rodríguez Esquíroz, N Larrea Goñi, R Juanbeltz Zurbano, P Aldave Cobos, L Ulacia Epelde, JA Illodo Becerra
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Palbociclib was approved by the EMA for the treatment of hormone receptor positive, human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aae1015319f7b2ea3511e1cd5f5726ea
https://doi.org/10.1136/ejhpharm-2020-eahpconf.203
https://doi.org/10.1136/ejhpharm-2020-eahpconf.203
Autor:
G Pinilla Lebrero, D Tejada Marín, J.J. Elizondo Armendáriz, B Larrayoz Sola, I Ortega Belio, R de la Riva Bohigas, J Polo García, A Rodríguez Esquíroz, P Aldave Cobos, L Ulacia Epelde, M Sarobe Carricas
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance A 65-year-old woman with Philadelphia chromosome positive acute lymphoblastic leukaemia was treated with dasatinib 140 mg daily. After the first dose, the patient experienced anaphylactic shock presenting poor general condit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfc5831c7ebd132a1be710eee3423b9b
https://doi.org/10.1136/ejhpharm-2020-eahpconf.367
https://doi.org/10.1136/ejhpharm-2020-eahpconf.367